High-end drugs have always been the focus of research and development in the medical field. With the support of various national policies, the research and development of innovative drugs in my country is on an upward trend. However, the packaging of high-end drugs has always been a concern in the industry. The material properties of polypropylene and polyethylene are not suitable for high-end drugs, but have high transparency and corrosion resistance, good storage performance, easy disinfection and sterilization, and low price. The glass bottle has the disadvantage of adsorbing protein, which greatly reduces the capacity of high-end drugs. Is there a material that not only has the advantages of glass bottles, but also has low protein adsorption performance?
5ml and 100ml cop vial
In fact, a material with low protein adsorption properties is gradually becoming the exclusive packaging of biological products and anti-tumor drugs, that is, the COP bottle. The raw material of COP is developed and produced by Zeon Company of Japan. It is used for medical optical components and high-end pharmaceutical packaging materials. It has high transparency, excellent low protein adsorption, low birefringence, good water vapor air tightness, and compatibility with medicines. There is no peeling in the test, and the color does not change after irradiation. It can be sterilized by high temperature and can also be used as a container for biological products and organic solutions that need to be frozen.
COP bottles are mainly used for high value-added drugs, such as lymphocyte antigens, hormone drugs, anesthetics, drugs with a PH value greater than 9 and items with accurate dosage requirements. Although the price of COP bottles is slightly higher than that of glass bottles, the drugs in their application fields generally have higher prices, and the low-protein adsorption characteristics of COP can greatly increase the value of drugs, saving pharmaceutical companies a part of the cost of pharmaceuticals. It is said that COP bottles are more suitable for high-end drugs.
Everything is constantly evolving and changing. Pharmaceutical companies must learn to look at problems with a developmental perspective. They should not only see the high price of COP bottles, but also pay attention to the value they bring to the market. At present, some domestic pharmaceutical companies have been in the forefront of the industry. For example, a COP bottle produced by a certain original research drug of CSPC and Xinfidel Pharmaceutical Packaging has passed the CDE related review in 2018 (registration number: B20180001378). Mass production of the drug is just around the corner. It is believed that with the continuous deepening of my country's innovative drug research and development, the COP bottle market will also usher in a leap-forward development.
Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights
MAKE AN ENQUIRY
